Physician profile
Ahmad Munir
NPI 1730145228
$175,686.97
in general payments reported to CMS, 2019-2025
38 companies · $1,478 in 2025
The $1,478 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,629 · 2020: $1,158 · 2021: $87K · 2022: $71K · 2023: $5,332 · 2024: $6,807 · 2025: $1,478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,276 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,375 · Travel and Lodging: $2,961 · Education: $6.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,276.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,375.00 |
| Travel and Lodging | $2,960.79 |
| Education | $6.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $160,413.80 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Inari Medical, INC. | $4,396.27 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $2,202.83 | 2019-2020 | |
| Abiomed | $2,152.15 | 2019-2025 | Impella |
| Abbott Laboratories | $1,013.69 | 2019-2025 | Cardiomems, Aveir, Gallant |
| Amgen INC. | $699.03 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $640.36 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $559.63 | 2020-2025 | |
| Actelion Pharmaceuticals US, INC. | $353.51 | 2019-2025 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $310.30 | 2019-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $309.45 | 2020-2025 | Onpattro |
| Edwards Lifesciences Corporation | $301.28 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $273.70 | 2019-2022 | |
| Boston Scientific Corporation | $257.01 | 2020-2025 | Cds - Mct/Cem Monitoring |
| E.R. Squibb & Sons, L.L.C. | $255.84 | 2022-2025 | Camzyos, Eliquis |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Munir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.